NASDAQ : LNTH
Lantheus Holdings, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 100.32 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.55B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 6.56B |
| Enterprise Value | 6.59B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 65.27M |
| Shares Outstanding | 65.27M |
| Shares Change (YoY) | -7.97% |
| Shares Change (QoQ) | +2.65% |
| Owned by Insiders (%) | 1.60% |
| Owned by Institutions (%) | 106.65% |
| Float | 58.61M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 24.19 |
| Forward PE | 17.66 |
| PS Ratio | 4.21 |
| Forward PS | 4.32 |
| PB Ratio | 5.00 |
| P/TBV Ratio | 17.10 |
| P/FCF Ratio | 16.91 |
| P/OCF Ratio | 15.88 |
| PEG Ratio | 1.21 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 23.93 |
| EV / Sales | 4.23 |
| EV / EBITDA | 16.80 |
| EV / EBIT | 21.69 |
| EV / FCF | 16.99 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.06 |
| Quick Ratio | 2.82 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 1.57 |
| Debt / FCF | 1.61 |
| Interest Coverage | 15.33 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 22.21% |
| Return on Assets (ROA) | 8.38% |
| Return on Invested Capital (ROIC) | 17.17% |
| Return on Capital Employed (ROCE) | 14.61% |
| Weighted Average Cost of Capital (WACC) | 4.21% |
| Revenue Per Employee | $1.30M |
| Profits Per Employee | $230,767 |
| Employee Count | 1,193 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 10.36 |
Taxes
| Measure | Value |
|---|
| Income Tax | 87.67M |
| Effective Tax Rate | 24.15% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.02 |
| 52-Week Price Change | +79.78% |
| 50-Day Moving Average | 100.26 |
| 200-Day Moving Average | 91.38 |
| Relative Strength Index (RSI) | 56.05 |
| Average Volume (20 Days) | 1,013,599 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.63M |
| Short Previous Month | 3.78M |
| Short % of Shares Out | 5.56% |
| Short % of Float | 6.20% |
| Short Ratio (days to cover) | 3.81 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.56B |
| Gross Profit | 936.02M |
| Operating Income | 303.72M |
| Pretax Income | 362.98M |
| Net Income | 275.31M |
| EBITDA | 392.23M |
| EBIT | 303.72M |
| Earnings Per Share (EPS) | $4.15 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 593.30M |
| Total Debt | 624.96M |
| Net Cash | -31.66M |
| Net Cash Per Share | -$0.49 |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 20.10 |
| Working Capital | 691.38M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 412.80M |
| Capital Expenditures | -24.97M |
| Depreciation & Amortization | 88.51M |
| Net Borrowing | -1.11M |
| Free Cash Flow | 387.83M |
| FCF Per Share | $5.94 |
Margins
| Measure | Value |
|---|
| Gross Margin | 60.14% |
| Operating Margin | 19.52% |
| Pretax Margin | 23.32% |
| Profit Margin | 17.69% |
| EBITDA Margin | 25.20% |
| EBIT Margin | 19.52% |
| FCF Margin | 24.92% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.97% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.13% |
| FCF Yield | 5.91% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $106.99 |
| Price Target Difference | 6.50% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 7.07% |
| EPS Growth Forecast (3Y) | 8.59% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.48 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |